C O M M U N I C A T I O N S
compared to anthracene or pyrene.9 ortho-PyNaph was therefore
synthesized by two successive Suzuki coupling reactions. Its crystal
structure confirmed the anticipated U-shape (Supporting Informa-
neutral medium (Figure 4A). This overall decrease in intensity at
pH 7.4 therefore results from the competing effects of (i) fluores-
cence enhancement by the PEG portion and (ii) significant
quenching by contact with the tweezing unit. In contrast, at pH
4.5, the PEG-tweezer did not quench quinizarin’s fluorescence and
the signal remained comparable to that obtained with the uncon-
jugated PEG (Figure 4B). A similar phenomenon was also observed
with mitoxantrone (Supporting Information). These findings point
to a greater affinity of both substrates for the PEG-tweezer under
neutral conditions, where it adopts a U-shape, than at acidic pH,
where the W conformation predominates.
1
tion). H NMR titration with trifluoroacetic acid showed that the
switching properties were maintained in the presence of naphthalene
groups (Figure 3). As far as the naphthalene protons were
concerned, chemical shifts were spread over the aromatic region
in the neutral form, significantly lower than that in free naphthalene
(Figure 3B, bottom). This observation is in agreement with the
mutual shielding of the aromatic groups, which face each other in
the neutral state. Upon addition of TFA, all the naphthalene protons
became deshielded and reached final chemical shifts in two clusters
(n3+n4+n7 and n1+n2+n5+n6), very similar to those of naphthalene
itself (Figure 3B, top). This effect is consistent with a conforma-
tional change from a U- to a W-shape where each naphthalene unit
no longer feels the electronic effect of its counterpart (Figure 3A).
Figure 4. Emission fluorescence of quinizarin (5 µM, λexc ) 490 nm) upon
the addition of PEG-tweezer (0 to 10 equiv), at pH 7.4 (A) and 4.5 (B).
Inset: structure of the substrates.
Overall, the PEG-tweezer reported herein, due to its water
solubility and pH responsiveness, may have potential to control
the release of drugs.
Acknowledgment. The NSERC (Steacie Fellowship to J.C.L.),
CRC program, Queen’s University, and the Canada Foundation for
Innovation are acknowledged for their financial support.
Supporting Information Available: Supporting figures, experi-
mental procedures, NMR, X-ray crystallographic data and mitoxantrone
binding studies. This material is available free of charge via the Internet
References
(1) (a) Rajendran, L.; Knolker, H.-J.; Simons, K. Nat. ReV. Drug DiscoVery
2010, 9, 29–42. (b) Duncan, R. Nat. ReV. Cancer 2006, 6, 688–701.
(2) (a) Guo, X.; Szoka, F. C. Acc. Chem. Res. 2003, 36, 335–341. (b) Ulbrich,
K.; Subr, V. AdV. Drug DeliVery ReV. 2004, 56, 1023–50. (c) Oh, K. T.;
Yin, H.; Lee, E. S.; Bae, Y. H. J. Mater. Chem. 2007, 17, 3987–4001. (d)
Yessine, M.-A.; Leroux, J.-C. AdV. Drug DeliVery ReV. 2004, 56, 999–
1021.
(3) (a) Gullotti, E.; Yeo, Y. Mol. Pharmaceut. 2009, 6, 1041–1051. (b)
Drummond, D. C.; Daleke, D. L. Chem. Phys. Lipids 1995, 75, 27–41. (c)
Walker, G. F.; Fella, C.; Pelisek, J.; Fahrmeir, J.; Boeckle, S.; Ogris, M.;
Wagner, E. Mol. Ther. 2005, 11, 418–425.
Figure 3. (A) Representation of the conformational change of ortho-
PyNaph upon protonation of the pyridine ring. (B) 400 MHz 1H NMR
spectral modifications of ortho-PyNaph (5.9 mM) upon addition of TFA
in 1:1 CDCl3/CD3OD and (top) chemical shifts of naphthalene in 1:1 CDCl3/
CD3OD.
(4) (a) Anslyn, E. V. J. Org. Chem. 2007, 72, 687–699. (b) Schneider, H.-J.
Angew. Chem., Int. Ed. 2009, 48, 3924–3977. (c) Liu, F.; Urban, M. W.
Prog. Polym. Sci. 2010, 35, 3–23.
(5) (a) Chen, C. W.; Whitlock, H. W. J. J. Am. Chem. Soc. 1978, 100, 4921–
4922. (b) Zimmerman, S. C. Top. Curr. Chem. 1993, 165, 71–102. (c)
Kla¨rner, F. G.; Kahlert, B. Acc. Chem. Res. 2003, 36, 919–932. (d) Harmata,
M. Acc. Chem. Res. 2004, 37, 862–873.
(6) (a) Petitjean, A.; Khoury, R. G.; Kyritsakas, N.; Lehn, J.-M. J. Am. Chem. Soc.
2004, 126, 6637–6647. (b) Landge, S. M.; Aprahamian, I. J. Am. Chem. Soc.
2009, 131, 18269–18271. (c) Skibinski, M.; Go´mez, R.; Lork, E.; Azov, V.
Tetrahedron 2009, 65, 10348–10354. (d) Legouin, B.; Uriac, P.; Tomasi, S.;
Toupet, L.; Bondon, A.; van de Weghe, P. Org. Lett. 2009, 11, 745–748.
(7) (a) Mu¨ller, B. K.; Reuter, A.; Simmel, F. C.; Lamb, D. C. Nano Lett. 2006,
6, 2814–2820. (b) Petitjean, A.; Lehn, J.-M. Inorg. Chim. Acta 2007, 360,
849–856. (c) Phillips, M. D.; Fyles, T. M.; Barwell, N. P.; James, T. D.
Chem. Commun. 2009, 43, 6557–6559.
(8) Parmentier, M.; Gros, P.; Fort, Y. Tetrahedron 2005, 61, 3261–3269.
(9) Nisbet, I. C. T.; LaGoy, P. K. Regul. Toxicol. Pharmacol. 1992, 16, 290–
300.
(10) (a) Law, S. L.; Ho, C. K.; Jang, T. F.; Chang, P.; Lin, F. M. Int. J. Pharm.
1996, 128, 139–143.
(11) Savko, M.; Kascakova, S.; Gbur, P.; Miskovsky, P.; Ulicny, J. THEOCHEM
2007, 823, 78–86.
Finally, the tweezer structure was grafted to a branched PEG
through position 4py of the pyridine to obtain a water-soluble
carrier. This was achieved through peptide coupling, resulting in a
50% grafting efficiency (Supporting Information). The drug binding/
release properties of the ortho-PyNaph tweezer were investigated
with two substrates: quinizarin and mitoxantrone, an anticancer
drug.10 Both molecules possess an aromatic moiety that can interact
with the two naphthalene units Via aromatic stacking, donor/
acceptor, as well as hydrophobic interactions (Figure 4). Quinizarin
was selected because of its fluorescence properties and the absence
of ionization in the studied pH range.11 As illustrated in Figure 4,
in aqueous conditions (pH 7.4 and 4.5), the addition of the free
PEG slightly enhanced the fluorescence intensity of quinizarin
(compare Dye alone and PEG), possibly due to the better dispersion
(and hence poorer self-quenching) of the dye. In this context, it is
particularly striking to notice that the PEG-tweezer actually led
to an overall decrease of fluorescence of the dye, and so only in
JA103153T
9
J. AM. CHEM. SOC. VOL. 132, NO. 25, 2010 8545